Journal profile · Toxicology
Mutation Research/Reviews in Mutation Research
ISSN 1383-5742 · eISSN 1388-2139 · Elsevier · NETHERLANDS · Bimonthly · Founded 1964
Mutation Research/Reviews in Mutation Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.4; hybrid open access; APC about USD 4,160; median 133 days to acceptance (60 articles, last 24 months); community-reported acceptance: fairly hard; 41 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Mutation Research/Reviews in Mutation Research is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Carcinogens and Genotoxicity Assessment, DNA Repair Mechanisms and Diverse Scientific and Economic Studies, together about 40.8% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The subject areas of Mutation Research - Reviews in Mutation Research (MRR) encompass the entire spectrum of the science of mutation research and its applications, with particular emphasis on the relationship between mutation and disease. Thus, this section will cover:Advances in human genome research (including evolving technologies for mutation detection and functional genomics) with applications in clinical genetics, gene therapy and health risk assessment for environmental agents of concernGenetic toxicology and environmental mutagenesis (including the factors that modulate the genetic activity of environmental agents) will continue to be prominent topics in this section.MRR supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chinese Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Genetic Toxicology and Environmental Mutagenesis (MRGTEM)
From the journal's Aims & Scope
Research area (LetPub): Toxicology
Editor-in-chief Brian ChorleyPublisher website
Editorial board by country: none in mainland China; most named United States 23, Italy 4, Canada 4, United Kingdom 2, Netherlands 2 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology20.7%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology14.6%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance5.6%
- Human auditory perception and evaluationEngineering5.6%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.5%
- Effects and risks of endocrine disrupting chemicalsEnvironmental Science4.4%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology3.8%
- Educational Robotics and EngineeringComputer Science3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
| Minor | Toxicology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
| Minor | Toxicology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Toxicology | Zone 1 |
| Minor | Biotechnology & Applied Microbiology | Zone 2 |
| Minor | Genetics & Heredity | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.4LetPub ·
- Impact factor (publisher)
- 6.5Publisher website ·
- CiteScore 2026-06
- 8.2LetPub ·
- CiteScore (publisher)
- 8.2Publisher website ·
- SJR 2026-06
- 1.58LetPub ·
- SNIP 2026-06
- 1.67LetPub ·
- h-index
- 114LetPub ·
- h-index
- 161OpenAlex ·
- i10-index
- 787OpenAlex ·
- 2-year mean citedness
- 4.08OpenAlex ·
- Self-citation rate
- 1.5%LetPub ·
- Share of gold OA articles
- 41.33%LetPub ·
Volume
- Articles per year
- 37LetPub ·
Articles by year OpenAlex count · 1,095 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 9 | 10 |
| 2025 | 41 | 23 | 131 |
| 2024 | 20 | 11 | 198 |
| 2023 | 22 | 14 | 424 |
| 2022 | 19 | 8 | 399 |
| 2021 | 37 | 17 | 1,907 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
133 daysMedian, submission to acceptance · P25–P75 94 days – 194 days
- Acceptance to online
- median 6 days (61 articles)
- Submission to online
- median 140 days
- Sample
- 60 articles with submission and acceptance dates (61 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15.7 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- First decision after review
- 92 daysPublisher website ·
- Submission to acceptance
- 137 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,160 / EUR 3,890 / GBP 3,330 / JPY 515,960 | — | — | |
| Publisher website | USD 3,980 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Highlights
- Optional
- Graphical abstract
- Optional
Article types accepted7
- full-length reviewsMutation Research - Reviews in Mutation Research publishes primarily full-length reviews comprehensively covering and critically analysing a topic.Length not stated
- mini-reviewsHowever, Mutation Research - Reviews in Mutation Research also publishes mini-reviews, reviews including meta- and informatic analyses, and invited papers in th…Length not stated
- reflections in mutation researchHowever, Mutation Research - Reviews in Mutation Research also publishes mini-reviews, reviews including meta- and informatic analyses, and invited papers in th…Length not stated
- reviewMutation Research - Reviews in Mutation Research publishes review articles only. Mutation Research - Reviews in Mutation Research publishes primarily full-lengt…Length not stated
- review articleMutation Research - Reviews in Mutation Research publishes review articles only. Mutation Research - Reviews in Mutation Research publishes primarily full-lengt…Length not stated
- review articlesMutation Research - Reviews in Mutation Research publishes review articles only.Length not stated
- reviews including meta- and informatic analysesHowever, Mutation Research - Reviews in Mutation Research also publishes mini-reviews, reviews including meta- and informatic analyses, and invited papers in th…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Ethics in publishing Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access policy Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Peer review policy Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1964
- ISSN
- 1383-5742
- Electronic ISSN
- 1388-2139
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Mutation Research/Reviews in Mutation Research
What CAS zone is Mutation Research/Reviews in Mutation Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Mutation Research/Reviews in Mutation Research is in Zone 2 of Medicine, and in Zone 2 of the minor category Biotechnology & Applied Microbiology / Genetics & Heredity / Toxicology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Mutation Research/Reviews in Mutation Research?
The latest impact factor listed by LetPub is 6.4; CiteScore 8.2, h-index 161.
How long does peer review take at Mutation Research/Reviews in Mutation Research?
Based on the dates recorded on 60 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 133 days (interquartile range 94–194 days); authors report an average review time of about 15.7 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Mutation Research/Reviews in Mutation Research?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Mutation Research/Reviews in Mutation Research based?
Of the 39 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (23), Italy (4) and Canada (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Mutation Research/Reviews in Mutation Research?
According to LetPub and DOAJ records, Mutation Research/Reviews in Mutation Research is indexed in SCIE and Scopus.
Is Mutation Research/Reviews in Mutation Research open access, and what is the APC?
Mutation Research/Reviews in Mutation Research is a hybrid journal. For open-access publication: APC about USD 4,160.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .